TerrAscend Corp.
TSX:TSND.TODrug Manufacturers - Specialty & Generic
-$0.02 today
- Market cap
- $193.65M
- Beta
- 2.04
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$0.26
Volume 0.26M
Average 0.31M
TSND.TO Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
TerrAscend Corp.TSX: TSND.TO
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue declines year over year
Q1 FY2026 revenue of $64.46M fell 9.2% year over year, in line with the -8.7% change in trailing-twelve-month revenue. Sequentially, it fell 4.0% from the prior quarter. Over 3 fiscal years it compounded at +3.3% a year.
Context
- Revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 3 analysts of $270.83M (+2.2%) for the fiscal year ending Dec 2026, a step up from the -13.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $64.46M-4.0% QoQ
- Last fiscal yearDec 2025
- $265.12M-13.6% YoY
- LTMMar 2026
- $261.74M-8.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -9.2% | +1.9% | +11.1 pp |
| 1 year | -13.6% | +2.2% | +15.7 pp |
| 3-year CAGR | +3.3% | +6.5% | +3.2 pp |
| 5-year CAGR | +6.5% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 265.12M USD
- Year-over-year change
- -13.6%
- 4-year CAGR
- +2.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 265.12M | -13.6% |
| FY2024 | 2024-12-31 | 306.68M | -3.4% |
| FY2023 | 2023-12-31 | 317.33M | +32.0% |
| FY2022 | 2022-12-31 | 240.45M | -1.2% |
| FY2021 | 2021-12-31 | 243.36M | — |
Revenue vs competitors
How TSND.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of -8.7% is the lowest of 9, against a peer median of +18.9%.
- Over three fiscal years its annual growth of +3.3% compares with a peer median of +11.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | CA$318.43M CAD | -7.2% | +11.2% | |
| LTM Mar 2026 | CA$310.92M CAD | +15.6% | -5.1% | |
| LTM Mar 2026 | $305.39M USD | +0.1% | -15.2% | |
| LTM Mar 2026 | CA$274.19M CAD | +41.3% | — | |
| LTM Mar 2026 | $261.74M USD | -8.7% | +3.3% | |
| LTM Mar 2026 | CA$158.57M CAD | +22.2% | +17.0% | |
| LTM Mar 2026 | $55.76M USD | -1.8% | -2.8% | |
| LTM Mar 2026 | $51.17M USD | +65.5% | +207.5% | |
| LTM Mar 2026 | $50.92M USD | +28.9% | +35.4% | |
| LTM Mar 2026 | $0 USD | — | — | |
| Peer median (excluding TSND.TO) | — | +18.9% | +11.2% | |
Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 243.36M | 240.45M | 317.33M | 306.68M | 265.12M |
| Cost of Revenue | 109.32M | 203.35M | 112.49M | 156.72M | 131.93M |
| Gross Profit | 134.04M | 119.74M | 138.02M | 149.96M | 133.19M |
| Gross Margin | 55.1% | 49.8% | 43.5% | 48.9% | 50.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 73.71M | 116.64M | 112.17M | 111.33M | 82.41M |
| Operating Expenses | 94.12M | 150.69M | 179.56M | 167.07M | 87.78M |
| Depreciation & Amortization | 13.63M | 24.6M | 22.7M | 22.99M | 17.51M |
| EBITDA | 44.96M | (246.52M) | (1.03M) | 6.16M | 62.92M |
| EBITDA Margin | 18.5% | -102.5% | -0.3% | 2.0% | 23.7% |
| Operating Income | 31.33M | (23.04M) | (19.87M) | (17.11M) | 45.41M |
| Operating Margin | 12.9% | -9.6% | -6.3% | -5.6% | 17.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 24.57M | 37.9M | 35.11M | 35.4M | 36.93M |
| Other Income / Expenses | 12.46M | (277.92M) | (38.97M) | (35.13M) | (40.34M) |
| Income Before Tax | 43.78M | (300.95M) | (58.83M) | (52.23M) | 5.06M |
| Pre-Tax Margin | 18.0% | -125.2% | -18.5% | -17.0% | 1.9% |
| Income Tax Expense | 28.88M | (10.46M) | 23.45M | 20.44M | 29.98M |
| Net Income | 3.06M | (303.96M) | (91.1M) | (80.23M) | (87.74M) |
| Net Margin | 1.3% | -126.4% | -28.7% | -26.2% | -33.1% |
| EPS (Basic) | 0.07 | (1.31) | (0.32) | (0.28) | (0.29) |
| EPS (Diluted) | 0.01 | (1.31) | (0.32) | (0.28) | (0.29) |
| Weighted Avg Shares | 181.06M | 244.35M | 279.29M | 291.51M | 301.08M |
| Weighted Avg Shares (Diluted) | 208.71M | 244.35M | 279.29M | 291.51M | 301.08M |
TerrAscend Corp.
TSX:TSND.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.